Trius Investigator Site 002 — Minneapolis, Minnesota

Trius Investigator Site 002 is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Trius Investigator Site 002 has participated in 2 clinical trials.

Therapeutic areas: Hepatic Impairment, Renal Impairment.

Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Trius Investigator Site 002?

Trius Investigator Site 002 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Trius Investigator Site 002 conducted?

Trius Investigator Site 002 has 2 clinical trials on record. Their work covers Hepatic Impairment, Renal Impairment.

Is Trius Investigator Site 002 accredited by Crixeo Clinical Trials?

Trius Investigator Site 002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Trius Investigator Site 002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.